Browse the evidence

The low glycemic load (LG) diet decreases depression-dejection (D) compared to the high glycemic load (HG) diet during caloric restriction.

Practitioners may consider recommending a low glycemic load diet to reduce feelings of depression during caloric restriction.

Bariatric endoscopy is becoming increasingly popular as a less invasive treatment option for obesity and associated nonalcoholic fatty liver disease (NAFLD).

Practitioners should consider bariatric endoscopy as a viable option for patients seeking less invasive weight loss solutions.

The effectiveness of ESG is influenced by the patient's body mass index (BMI), being more effective in those with lower BMIs.

Practitioners should assess BMI when recommending ESG to optimize treatment outcomes.

Lifestyle interventions are the backbone of obesity therapy but may be challenging to implement in transplant candidates.

Practitioners should consider the unique challenges faced by transplant candidates when recommending lifestyle changes.

Sleeve gastrectomy can result in weight loss up to 23% at 1 year and is associated with a lower risk of malabsorption compared to Roux-en-Y gastric bypass.

Surgeons and healthcare providers should consider sleeve gastrectomy as a viable option for weight loss in transplant candidates.

Obesity is often associated with sleep disorders, which can lead to further obesity.

Addressing sleep quality may be crucial in obesity management strategies.

Diabetic nephropathy significantly increases cardiovascular risk.

Monitoring cardiovascular health is crucial for T2D patients with diabetic nephropathy.

Die Gewichtsentwicklung in den ersten Wochen bis Monaten nach Initialisierung einer Therapie ist der stärkste Prädiktor für Gewichtszunahme assoziiert mit AP und AD.

Monitoring weight in the early stages of treatment can help predict long-term outcomes.

Understanding factors associated with paraspinal muscle atrophy can help develop personalized rehabilitation protocols for postoperative recovery.

Practitioners can use these findings to tailor rehabilitation strategies for better recovery outcomes.

The Open Formulary group had a mean reduction in A1c of −2.7 ± 2.4, which was significantly greater than the Restrictive Formulary group's reduction of −0.74 ± 2.1.

Practitioners may consider that an open formulary can lead to better glycemic control in patients with type 2 diabetes.

The Open Formulary group had a modest weight reduction of −2.5 kg ± 4.4 kg.

Practitioners may note that an open formulary can also contribute to modest weight loss in patients.

Effective policies and strategies for the prevention of overweight and obesity are urgently required.

Policymakers should prioritize the development of effective obesity prevention strategies.

The intervention group achieved only a modest long-term difference in weight loss compared with the control group.

Practitioners should manage expectations regarding weight loss outcomes from intensive lifestyle interventions.

The mean taste rating for fruits and vegetables (F/V) was significantly higher (7.1±1.5) than for mixed dishes/snacks (M/S) (6.8±1.5) (p=0.035).

Practitioners may consider promoting fruits and vegetables over mixed dishes/snacks to enhance dietary preferences.

Higher food sugar and sodium content, %energy from fat, and lower energy density independently predicted higher taste ratings.

Nutritional content should be considered when aiming to enhance food appeal.

Taste ratings were positively associated with dietary restraint, variability in daily energy intake, and sleep duration, and inversely associated with hunger and uncontrolled eating.

Understanding these associations can help in designing interventions to improve dietary habits.

Obesity predicts cardiovascular disease mortality.

Practitioners should consider obesity as a significant risk factor for cardiovascular disease mortality.

Higher BMIs are associated with the development of chronic kidney disease.

Weight management may be crucial for preventing chronic kidney disease.

The association between adiposity and cardiovascular events is linear above specific BMI thresholds.

Understanding BMI thresholds can help in assessing cardiovascular risk.

The guidelines focus on cardiovascular risk stratification and management of cardiovascular risk factors in diabetes.

Practitioners should implement risk stratification and management strategies for cardiovascular health in diabetic patients.

The guidelines aim to reduce the risk of heart failure and chronic kidney disease in individuals with diabetes.

Practitioners should focus on strategies to mitigate the risk of heart failure and kidney disease in diabetic patients.

Obesity and diabetes mellitus are major risk factors for the development and progression of chronic kidney disease (CKD).

Healthcare providers should prioritize screening for CKD in patients with obesity and diabetes.

In patients with cardiovascular disease and diabetes mellitus, lower-extremity muscle strength is significantly associated with peak oxygen uptake (VO 2peak).

Practitioners should focus on improving lower-extremity muscle strength in patients with CVD and DM to enhance exercise capacity.

The interaction between diabetes mellitus and lower-extremity muscle strength significantly affects exercise capacity.

Understanding the interaction between diabetes and muscle strength can help tailor exercise programs for better outcomes.